U.S. Electric Utilities Stock News

NasdaqGM:VERI
NasdaqGM:VERISoftware

A Look At Veritone (VERI) Valuation As Lawsuits And Restated Financials Pressure The Share Price

Veritone (VERI) is back in focus after multiple law firms filed class action lawsuits alleging misstatements in its financial reporting, following the company’s disclosures about overstated revenue, deficient controls, and required restatements. See our latest analysis for Veritone. Those accounting disclosures and the new US$50 million at the market offering have come against a weak backdrop, with the share price down 55.32% year to date and a 1 year total shareholder return of 22.64%...
NYSE:KR
NYSE:KRConsumer Retailing

Is Kroger (KR) Pricing Look Interesting After Mixed Returns And Rich P/E Multiple?

Wondering if Kroger at US$67.25 is offering fair value or if you might be paying over the odds for those groceries in your portfolio? The stock has returned 1.9% over the last 7 days, 0.0% over the past 30 days, 6.8% year to date, 0.1% over 1 year, 51.9% over 3 years and 102.3% over 5 years, so the recent share price sits against a mixed backdrop of shorter and longer term results. Recent coverage has focused on Kroger's position in US consumer retailing, including ongoing scrutiny of its...
NasdaqGM:LNTH
NasdaqGM:LNTHMedical Equipment

Is It Too Late To Consider Lantheus Holdings (LNTH) After Its Strong Share Price Run?

This article is designed to help you think through whether Lantheus Holdings, at around US$103, is still offering value or if most of the opportunity is already priced in. The stock has shown strong recent price action, with returns of 9.7% over the past week, 22.1% over the past month, 53.1% year to date, and 39.5% over the past year. Recent coverage has focused on Lantheus as a specialist in medical imaging and diagnostics, with investors closely watching how its product portfolio...
NasdaqGS:INTA
NasdaqGS:INTASoftware

Intapp Expands AI Timekeeping As Shares Trade Below Analyst Targets

Intapp (NasdaqGS:INTA) has introduced new AI powered features in Intapp Time, focused on helping professional services firms manage time and revenue capture more efficiently. The latest release includes AI work code prediction, configurable narrative tone enforcement, and upgraded mobile timekeeping tools. The update expands the use of AI across Intapp's cloud product suite for professional services clients. Intapp operates in the professional services technology space, where firms depend...
NasdaqGS:ALMS
NasdaqGS:ALMSPharmaceuticals

How Alumis’ Revenue Slide but Smaller Per-Share Loss Will Impact Alumis (ALMS) Investors

Alumis Inc. recently reported its first-quarter 2026 results, with revenue of US$1.74 million compared with US$17.39 million a year earlier and a net loss of US$93.05 million versus US$98.96 million. Despite the sharp revenue drop, the company narrowed its basic loss per share from continuing operations to US$0.74, down from US$1.82, highlighting shifting cost and earnings dynamics. Next, we’ll examine how Alumis’s sharply lower revenue but reduced loss per share shapes the company’s broader...
NYSE:RVTY
NYSE:RVTYLife Sciences

Is It Time To Reassess Revvity (RVTY) After Its Recent Share Price Rebound?

Wondering whether Revvity at about US$96.95 is offering fair value or a potential mispricing opportunity? This article walks through the key signals to help you frame that question clearly. The stock has recently gained 3.2% over the last 7 days and 11.7% over the last 30 days, even though it is still down 1.2% year to date. Its 3 year and 5 year returns of 16.2% and 32.4% respectively are also in decline. Recent coverage has focused on Revvity’s position within life sciences and...
NasdaqGS:HTHT
NasdaqGS:HTHTHospitality

Assessing H World Group (NasdaqGS:HTHT) Valuation After Recent Share Price Weakness

What recent price moves say about H World Group H World Group (NasdaqGS:HTHT) has drawn fresh attention after the stock declined about 3.4% in the past day, adding to falls of roughly 2.7% over the week and 13% over the past month. See our latest analysis for H World Group. Set against a 1-year total shareholder return of 29.38% and a 3-year total shareholder return of 33.83%, the recent 30-day share price return of down 13.48% suggests positive long-term wealth creation but fading...
NYSE:CTRA
NYSE:CTRAOil and Gas

A Look At Coterra Energy (CTRA) Valuation After Its Form 15 Deregistration Move

Coterra Energy (CTRA) has moved to voluntarily deregister its common stock and several senior notes by filing Form 15 with the SEC, marking a material shift in its reporting and disclosure obligations for investors. See our latest analysis for Coterra Energy. The share price has reacted sharply around these filings, with a 1-day share price return down 8.62% and a 7-day share price return down 7.97%. This follows a year-to-date share price return of 22.41% and a 1-year total shareholder...
NasdaqGS:PTRN
NasdaqGS:PTRNMultiline Retail

Assessing Pattern Group (PTRN) Valuation After Revenue Losses And Strong Recent Share Price Momentum

Pattern Group (PTRN) has drawn fresh attention after reporting annual revenue of US$2.73b, alongside a net loss of US$143.04m, putting its e-commerce accelerator model and underlying profitability under closer investor review. See our latest analysis for Pattern Group. At a share price of US$18.22, Pattern Group has seen strong short term momentum, with a 30 day share price return of 34.96% and a 90 day share price return of 89.40%, hinting that investors are reassessing both growth potential...
NYSE:DAC
NYSE:DACShipping

How Strong Q1 2026 Results and Dividend Decision Will Impact Danaos (DAC) Investors

Danaos Corporation reported past first-quarter 2026 results with sales of US$253.7 million, net income of US$140.42 million, and basic earnings per share of US$7.71, and declared a US$0.90 per-share dividend payable on June 4, 2026 to stockholders of record on May 26, 2026. The combination of higher earnings and an ongoing dividend payout highlights Danaos’s ability to convert its contracted shipping activity into solid profitability and shareholder cash returns. We’ll now examine how...
NYSE:ASH
NYSE:ASHChemicals

How Investors Are Reacting To Ashland (ASH) Board Refresh And Rising Activist Investor Pressure

Ashland Inc. recently added Bertrand Loy, executive chair and former chief executive officer of Entegris Inc., to its board and participated in Suppliers' Day 2026 at the Javits Center in New York, events that occurred in May 2026. These corporate governance changes and industry-facing activities have coincided with activist investors disclosing sizeable positions in Ashland, increasing attention on how the company may be run and overseen. Next, we’ll explore how rising activist investor...
NasdaqCM:AHG
NasdaqCM:AHGHealthcare

What Does Akso Health (AHG)'s Auditor Switch Reveal About Its Governance And Transparency Priorities?

On May 12, 2026, Akso Health Group’s audit committee dismissed Onestop Assurance PAC as its independent registered public accounting firm and appointed CHI-LLTC as the new auditor, effective immediately. This change in external auditor highlights a meaningful shift in Akso Health Group’s approach to financial oversight and corporate governance transparency. We will now examine how the shift from Onestop Assurance PAC to CHI-LLTC may influence Akso Health Group’s investment narrative. Invest...
NasdaqGM:EYPT
NasdaqGM:EYPTPharmaceuticals

A Look At EyePoint (EYPT) Valuation As DURAVYU Phase 3 Safety Review Keeps Trials On Track

The latest review by the independent Data Safety Monitoring Committee of EyePoint (EYPT) pivotal Phase 3 DURAVYU program kept both LUGANO and LUCIA trials on course, with interim masked data indicating a continued favorable safety profile. See our latest analysis for EyePoint. EyePoint’s recent safety update for DURAVYU comes after a sharp share price pullback this year, with the stock down 26.03% on a year to date share price return but still showing a 127.64% total shareholder return over...
NasdaqCM:NGEN
NasdaqCM:NGENPharmaceuticals

Assessing NervGen Pharma (NasdaqCM:NGEN) Valuation After Its $60 Million Follow On Equity Offering

NervGen Pharma (NGEN) has drawn fresh attention after completing a follow on public equity offering of approximately $60 million, including common shares and warrants, to fund its neuroreparative drug development programs. See our latest analysis for NervGen Pharma. The follow on offering has coincided with sharp share price pressure, with NervGen Pharma’s 1 day share price return down 43.48% and its year to date share price return down 64.63%. This comes even though the 5 year total...
NYSE:TK
NYSE:TKOil and Gas

Teekay (TK) Valuation Check As Rebranding Earnings Strength And Special Dividend Draw Investor Focus

Teekay (TK) has moved back onto investor radars after reporting first quarter 2026 sales of US$286.09 million and net income of US$153.55 million, alongside a US$1.00 per share special dividend announcement. See our latest analysis for Teekay. The recent special dividend and first quarter earnings update come after a period of strong momentum, with a year to date share price return of 51.25% and a 1 year total shareholder return of 82.14%, suggesting improving sentiment around Teekay’s...
NYSE:DAN
NYSE:DANAuto Components

How Dana’s One-Off Driven Profit Surge Reshapes the Core Earnings Story for Investors (DAN)

In May 2026, Dana Incorporated reported past first-quarter 2026 results showing sales of US$1,868 million versus US$1,781 million a year earlier, with net income rising to US$1.09 billion from US$25 million, while still recording a basic loss per share of US$0.17 from continuing operations. The contrast between the very large net income and the loss per share from continuing operations suggests that one-off or non-core items played a major role in shaping overall profitability. We’ll now...